Showing results (571-580 of 1,242) with videos related to
Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 3, 2025
Type 2 diabetes mellitus, antidiabetics, and the risk of amyotrophic lateral sclerosisTian-Shin Yeh, Ran S Rotem, Marc G WeisskopfAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 6, 2025
Toward therapeutic trials in primary lateral sclerosisErica Scirocco, Matti D Allen, Elisa Giacomelli, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 16, 2025
Understanding the uptake and use of noninvasive ventilation among Australians living with amyotrophic lateral sclerosis: results of a national surveyMarnie Graco, Kate A Carey, Kylie Russo, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 14, 2025
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium datasetAndres Arguedas, David Schneck, Erjia Cui, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 20, 2025
Self-care mobile application for people with Amyotrophic Lateral Sclerosis: a development and usability testJuyeon Oh, Hyeon Sik ChuAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2025
ALSUntangled #79: alpha-lipoic acidAlaina Giacobbe, James Hiana, Olivia Wang, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 26, 2025
Cross-cultural adaptation and psychometric evaluation of a Turkish version of the Amyotrophic Lateral Sclerosis-Specific Quality of Life-Short FormErsin Uskun, Nafiye Turkmenel, Suleyman KutluhanAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 11, 2025
Epidemiology of amyotrophic lateral sclerosis: a population-based analysis, 2015-2020Bernat Bertran-Recasens, Sergio Vidal-Notari, Guillem Hernández Guillamet, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2025
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's diseaseFederico Garrou, Fabiola De Marchi, Lucia Corrado, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 1, 2025
Repurposing FDA-approved drugs for treatment of amyotrophic lateral sclerosis using machine learningSaanvi Dogra, Valentina L Kouznetsova, Igor F TsigelnyPageof 125